SUTHON, Sarocha, Rachel S. PERKINS, Vítězslav BRYJA, Gustavo A. MIRANDA-CARBONI and Susan A. KRUM. WNT5B in Physiology and Disease. Frontiers in Cell and Developmental Biology. Lausanne: Frontiers Media S.A., 2021, vol. 09, May, p. "667581", 20 pp. ISSN 2296-634X. Available from: https://dx.doi.org/10.3389/fcell.2021.667581.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name WNT5B in Physiology and Disease
Authors SUTHON, Sarocha, Rachel S. PERKINS, Vítězslav BRYJA (203 Czech Republic, belonging to the institution), Gustavo A. MIRANDA-CARBONI and Susan A. KRUM (guarantor).
Edition Frontiers in Cell and Developmental Biology, Lausanne, Frontiers Media S.A. 2021, 2296-634X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.081
RIV identification code RIV/00216224:14310/21:00121666
Organization unit Faculty of Science
Doi http://dx.doi.org/10.3389/fcell.2021.667581
UT WoS 000651394300001
Keywords in English WNT5B; WNT signaling; development; cancer; WNT5A
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 28/5/2021 14:33.
Abstract
WNT5B, a member of the WNT family of proteins that is closely related to WNT5A, is required for cell migration, cell proliferation, or cell differentiation in many cell types. WNT5B signals through the non-canonical beta-catenin-independent signaling pathway and often functions as an antagonist of canonical WNT signaling. Although WNT5B has a high amino acid identity with WNT5A and is often assumed to have similar activities, WNT5B often exhibits unique expression patterns and functions. Here, we describe the distinct effects and mechanisms of WNT5B on development, bone, adipose tissue, cardiac tissue, the nervous system, the mammary gland, the lung and hematopoietic cells, compared to WNT5A. We also highlight aberrances in non-canonical WNT5B signaling contributing to diseases such as osteoarthritis, osteoporosis, obesity, type 2 diabetes mellitus, neuropathology, and chronic diseases associated with aging, as well as various cancers.
Links
EF16_025/0007381, research and development projectName: Preklinická progrese nových organických sloučenin s cílenou biologickou aktivitou
PrintDisplayed: 28/4/2024 09:29